Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990226486> ?p ?o ?g. }
- W1990226486 endingPage "532" @default.
- W1990226486 startingPage "528" @default.
- W1990226486 abstract "Saccharomyces cerevisiae is engineered to produce high concentrations of artemisinic acid, a precursor of the artemisinin used in combination therapies for malaria treatment; an efficient and practical chemical process to convert artemisinic acid to artemisinin is also developed. Artemisinin-based combination therapies are the treatment of choice for uncomplicated Plasmodium falciparum malaria, but the supply of plant-derived artemisinin can sometimes be unreliable, causing shortages and high prices. This manuscript describes a viable industrial process for the production of semisynthetic artemisinin, with the potential to help stabilize artemisinin supply. The process uses Saccharomyces cerevisiae yeast engineered to produce high yields of artemisinic acid, a precursor of artemisinin. The authors have also developed an efficient and scalable chemical process to convert artemisinic acid to artemisinin. In 2010 there were more than 200 million cases of malaria, and at least 655,000 deaths1. The World Health Organization has recommended artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum. Artemisinin is a sesquiterpene endoperoxide with potent antimalarial properties, produced by the plant Artemisia annua. However, the supply of plant-derived artemisinin is unstable, resulting in shortages and price fluctuations, complicating production planning by ACT manufacturers2. A stable source of affordable artemisinin is required. Here we use synthetic biology to develop strains of Saccharomyces cerevisiae (baker’s yeast) for high-yielding biological production of artemisinic acid, a precursor of artemisinin. Previous attempts to produce commercially relevant concentrations of artemisinic acid were unsuccessful, allowing production of only 1.6 grams per litre of artemisinic acid3. Here we demonstrate the complete biosynthetic pathway, including the discovery of a plant dehydrogenase and a second cytochrome that provide an efficient biosynthetic route to artemisinic acid, with fermentation titres of 25 grams per litre of artemisinic acid. Furthermore, we have developed a practical, efficient and scalable chemical process for the conversion of artemisinic acid to artemisinin using a chemical source of singlet oxygen, thus avoiding the need for specialized photochemical equipment. The strains and processes described here form the basis of a viable industrial process for the production of semi-synthetic artemisinin to stabilize the supply of artemisinin for derivatization into active pharmaceutical ingredients (for example, artesunate) for incorporation into ACTs. Because all intellectual property rights have been provided free of charge, this technology has the potential to increase provision of first-line antimalarial treatments to the developing world at a reduced average annual price." @default.
- W1990226486 created "2016-06-24" @default.
- W1990226486 creator A5000312223 @default.
- W1990226486 creator A5002211873 @default.
- W1990226486 creator A5003247246 @default.
- W1990226486 creator A5007933747 @default.
- W1990226486 creator A5008206625 @default.
- W1990226486 creator A5013085430 @default.
- W1990226486 creator A5018889682 @default.
- W1990226486 creator A5020766771 @default.
- W1990226486 creator A5022192729 @default.
- W1990226486 creator A5022980048 @default.
- W1990226486 creator A5023166021 @default.
- W1990226486 creator A5025390528 @default.
- W1990226486 creator A5026559801 @default.
- W1990226486 creator A5029682993 @default.
- W1990226486 creator A5030279412 @default.
- W1990226486 creator A5032826326 @default.
- W1990226486 creator A5039053483 @default.
- W1990226486 creator A5039166209 @default.
- W1990226486 creator A5039189321 @default.
- W1990226486 creator A5040737787 @default.
- W1990226486 creator A5042374779 @default.
- W1990226486 creator A5043767826 @default.
- W1990226486 creator A5043869883 @default.
- W1990226486 creator A5051052956 @default.
- W1990226486 creator A5052289464 @default.
- W1990226486 creator A5057071320 @default.
- W1990226486 creator A5058146470 @default.
- W1990226486 creator A5059568374 @default.
- W1990226486 creator A5059914924 @default.
- W1990226486 creator A5060239424 @default.
- W1990226486 creator A5060293264 @default.
- W1990226486 creator A5063989231 @default.
- W1990226486 creator A5065032254 @default.
- W1990226486 creator A5065447942 @default.
- W1990226486 creator A5065632239 @default.
- W1990226486 creator A5067077837 @default.
- W1990226486 creator A5067561540 @default.
- W1990226486 creator A5068175553 @default.
- W1990226486 creator A5072578321 @default.
- W1990226486 creator A5073358487 @default.
- W1990226486 creator A5075489021 @default.
- W1990226486 creator A5075975538 @default.
- W1990226486 creator A5076174243 @default.
- W1990226486 creator A5080645940 @default.
- W1990226486 creator A5081217766 @default.
- W1990226486 creator A5082157018 @default.
- W1990226486 creator A5084704699 @default.
- W1990226486 creator A5085068724 @default.
- W1990226486 creator A5086499099 @default.
- W1990226486 creator A5091477468 @default.
- W1990226486 date "2013-04-01" @default.
- W1990226486 modified "2023-10-18" @default.
- W1990226486 title "High-level semi-synthetic production of the potent antimalarial artemisinin" @default.
- W1990226486 cites W1530602575 @default.
- W1990226486 cites W1545509204 @default.
- W1990226486 cites W1877459560 @default.
- W1990226486 cites W1963880239 @default.
- W1990226486 cites W1969943057 @default.
- W1990226486 cites W1969962785 @default.
- W1990226486 cites W1977969711 @default.
- W1990226486 cites W1997859335 @default.
- W1990226486 cites W1999112888 @default.
- W1990226486 cites W2001859397 @default.
- W1990226486 cites W2012714287 @default.
- W1990226486 cites W2027324760 @default.
- W1990226486 cites W2033812623 @default.
- W1990226486 cites W2035045727 @default.
- W1990226486 cites W2061459669 @default.
- W1990226486 cites W2071695336 @default.
- W1990226486 cites W2072369409 @default.
- W1990226486 cites W2074965129 @default.
- W1990226486 cites W2075579534 @default.
- W1990226486 cites W2109646341 @default.
- W1990226486 cites W2118173936 @default.
- W1990226486 cites W2123380574 @default.
- W1990226486 cites W2128897939 @default.
- W1990226486 cites W2129447528 @default.
- W1990226486 cites W2140548225 @default.
- W1990226486 cites W2149202606 @default.
- W1990226486 cites W4234143043 @default.
- W1990226486 cites W4235784073 @default.
- W1990226486 doi "https://doi.org/10.1038/nature12051" @default.
- W1990226486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23575629" @default.
- W1990226486 hasPublicationYear "2013" @default.
- W1990226486 type Work @default.
- W1990226486 sameAs 1990226486 @default.
- W1990226486 citedByCount "1542" @default.
- W1990226486 countsByYear W19902264862012 @default.
- W1990226486 countsByYear W19902264862013 @default.
- W1990226486 countsByYear W19902264862014 @default.
- W1990226486 countsByYear W19902264862015 @default.
- W1990226486 countsByYear W19902264862016 @default.
- W1990226486 countsByYear W19902264862017 @default.
- W1990226486 countsByYear W19902264862018 @default.
- W1990226486 countsByYear W19902264862019 @default.
- W1990226486 countsByYear W19902264862020 @default.